8% Off
Vastarel MR35 mg
Trimetazidine Dihydrochloride
Servier Bangladesh Operation
৳276.00
Add to cart
Angirid MR35 mg
Trimetazidine Dihydrochloride
ACME Laboratories Ltd.
Product Code : 1036
10% Off
Best PriceTk
/
1
Alternatives
See All
10% Off
Metacard MR35 mg
Trimetazidine Dihydrochloride
Aristopharma Ltd.
৳126.00
Add to cart
10% Off
Vestar MR35 mg
Trimetazidine Dihydrochloride
Healthcare Pharmacuticals Ltd.
৳72.00
Add to cart
10% Off
Metazine MR35 mg
Trimetazidine Dihydrochloride
Beximco Pharmaceuticals Ltd.
৳81.00
Add to cart
10% Off
Feelnor MR35 mg
Trimetazidine Dihydrochloride
Incepta Pharmaceuticals Ltd.
৳60.75
Add to cart
10% Off
Antoris MR35 mg
Trimetazidine Dihydrochloride
Opsonin Pharma Ltd.
৳94.50
Add to cart
10% Off
Angivent MR35 mg
Trimetazidine Dihydrochloride
Square Pharmaceuticals Ltd.
৳72.00
Add to cart
10% Off
Metavas MR35 mg
Trimetazidine Dihydrochloride
NIPRO JMI Pharma Ltd.
৳72.00
Add to cart
10% Off
Trimet-MR35 mg
Trimetazidine Dihydrochloride
Drug International Ltd.
৳88.20
Add to cart
10% Off
Cardimet MR35 mg
Trimetazidine Dihydrochloride
Eskayef Bangladesh Ltd.
৳72.00
Add to cart
7% Off
Trangit MR35 mg
Trimetazidine Dihydrochloride
SANDOZ (A Novartis Division)
৳107.68
Add to cart
10% Off
Angivas MR35 mg
Trimetazidine Dihydrochloride
Popular Pharmaceuticals Ltd.
৳4.50
Add to cart
10% Off
Trimacontin35 mg
Trimetazidine Dihydrochloride
Mundipharma (BD) Pvt. Ltd.
৳8.10
Add to cart
10% Off
Angimet MR35 mg
Trimetazidine Dihydrochloride
Orion Pharma Ltd.
৳5.40
Add to cart
10% Off
Anginox MR35 mg
Trimetazidine Dihydrochloride
General Pharmaceuticals Ltd.
৳5.40
Add to cart
10% Off
Angitrim MR35 mg
Trimetazidine Dihydrochloride
Globe Pharmaceuticals Ltd.
৳5.40
Add to cart
10% Off
Trangina MR35 mg
Trimetazidine Dihydrochloride
Biopharma Laboratories Ltd.
৳54.00
Add to cart
10% Off
Vaspec MR35 mg
Trimetazidine Dihydrochloride
Navana Pharmaceuticals Ltd.
৳5.40
Add to cart
Medicine overview
Indications of Angirid MR 35 mg
Angirid MR 35 mg is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line antianginal therapies.
Theropeutic Class
Other Anti-anginal & Anti-ischaemic drugs
Pharmacology
Angirid MR 35 mg is the first 3- keto acyl CoA thiolase inhibitor (KAT), a metabolic anti-ischemic agent with proven benefits for all coronary patients. Angirid MR 35 mg inhibits fatty acid pathway by inhibiting 3-keto acyl CoA thiolase enzyme and transfers oxygen to glucose pathway. Since glucose pathway is more efficient in producing energy, the same oxygen produces more energy and makes the heart more active. Moreover, the aerobic oxidation of glucose stops production of lactic acid, which prevents angina pectoris.
Dosage & Administration of Angirid MR 35 mg
The recommended dose of Trimetazidine is 35 mg twice daily or 20 mg tablet thrice daily during meals. The benefit of the treatment should be assessed after three months and Trimetazidine should be discontinued if there is no treatment response.
Dosage of Angirid MR 35 mg
The recommended dose of Trimetazidine is 35 mg twice daily or 20 mg tablet thrice daily during meals. The benefit of the treatment should be assessed after three months and Trimetazidine should be discontinued if there is no treatment response.
Interaction of Angirid MR 35 mg
No drug interaction so far has been reported. In particular, no interaction has been reported with beta-blockers, calcium antagonists, nitrates, heparin, hypolipidemic agents or digitalis preparation.
Contraindications
Trimetazidine is contraindicated in patients who have hypersensitivity to the active substance or to any of the excipients. It is also is contraindicated in patients with Parkinson’s disease, parkinsonian symptoms, tremors, restless legs movement disorders, severe renal impairment.
Side Effects of Angirid MR 35 mg
Trimetazidine is safe and well tolerated. The Common side effects associated with Trimetazidine are dizziness, headache, abdominal pain, diarrhoea, dyspepsia, nausea, vomiting, rash, pruritus, urticaria and asthenia
Pregnancy & Lactation
There is no data on the use of Trimetazidine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. As a precautionary measure, it is preferable to avoid the use of Trimetazidine during pregnancy. It is unknown whether Trimetazidine is excreted in human milk. A risk to the newborns/infants cannot be excluded. Trimetazidine should not be used during breast-feeding.
Precautions & Warnings
Trimetazidine is not a curative treatment for angina attacks, nor an initial treatment for unstable angina pectoris. It is also not a treatment for myocardial infarction.
Storage Conditions
Keep in a dry place away from light and heat. Keep out of the reach of children.
Drug Classes
Other Anti-anginal & Anti-ischaemic drugs
Mode Of Action
Angirid MR 35 mg is the first 3- keto acyl CoA thiolase inhibitor (KAT), a metabolic anti-ischemic agent with proven benefits for all coronary patients. Angirid MR 35 mg inhibits fatty acid pathway by inhibiting 3-keto acyl CoA thiolase enzyme and transfers oxygen to glucose pathway. Since glucose pathway is more efficient in producing energy, the same oxygen produces more energy and makes the heart more active. Moreover, the aerobic oxidation of glucose stops production of lactic acid, which prevents angina pectoris.
Pregnancy
There is no data on the use of Trimetazidine in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. As a precautionary measure, it is preferable to avoid the use of Trimetazidine during pregnancy. It is unknown whether Trimetazidine is excreted in human milk. A risk to the newborns/infants cannot be excluded. Trimetazidine should not be used during breast-feeding.
Disclaimer
The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.